Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-23
    E.g., 2018-10-23

Archive Search

Pages

42 results
11:18 AM, Sep 28, 2018  |  BC Week In Review | Company News  |  Deals

Everest adds another antibiotic to pipeline through VenatoRx deal

bacterial pneumonia (HABP/VABP). VNRX-5133 is an IV broad-spectrum beta lactamase (LACTB) inhibitor; cefepime is a cephalosporin antibiotic
11:55 AM, Oct 27, 2017  |  BC Week In Review | Company News  |  Deals

NIH, Geom to conduct Phase I of GT-1

The double-blind, placebo-controlled, dose-escalation study will evaluate safety and pharmacokinetics in healthy volunteers. GT-1, a cephalosporin antibiotic
2:40 PM, Sep 29, 2017  |  BC Week In Review | Company News  |  Deals

Basilea grants China Resources Holdings rights to Zevtera in China

hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP). Zevtera is a prodrug of ceftobiprole, a broad-spectrum cephalosporin antibiotic
1:04 PM, Nov 11, 2016  |  BC Week In Review | Company News  |  Deals

Eli Lilly, Eddingpharm deal

introduce 10 new drugs to the China market over the next decade. Ceclor is a cephalosporin antibiotic
12:00 AM, Sep 19, 2016  |  BC Week In Review | Company News  |  Deals

Basilea, Grupo Biotoscana deal

is a broad-spectrum, water-soluble azole antifungal, and Zevtera is a prodrug of ceftobiprole, a broad-spectrum cephalosporin antibiotic
12:00 AM, Sep 05, 2016  |  BC Week In Review | Company News  |  Deals

AstraZeneca, Pfizer deal

commercialization rights in North America; it is known as Avycaz in the U.S. Zinforo, a cephalosporin antibiotic
12:00 AM, Apr 25, 2016  |  BC Week In Review | Company News  |  Other News

Basilea, Department of Health and Human Services infectious news

million to support Phase III trials of the company’s ceftobiprole medocaril. Basilea markets the broad-spectrum cephalosporin antibiotic
12:00 AM, Nov 23, 2015  |  BC Week In Review | Company News  |  Deals

Shionogi, GlaxoSmithKline deal

siderophore cephalosporin that is in Phase II testing to treat urinary tract infections (UTI). The cephalosporin antibiotic
12:00 AM, Nov 16, 2015  |  BC Week In Review | Company News  |  Deals

Basilea, Hikma Pharmaceuticals deal

hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP). Zevtera is a prodrug of ceftobiprole, a broad-spectrum cephalosporin antibiotic
12:00 AM, Dec 15, 2014  |  BC Week In Review | Company News  |  Sales & Marketing

Basilea sales and marketing update

launched Zevtera ceftobiprole in Germany to treat bacterial lung infections. The product is a broad-spectrum cephalosporin antibiotic

Pages